Global X Funds - Global X Genomics & Biotechnology ETF
GNOM
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.32B
Close$
$13.15
73.2% downside
Current Fair Value
73.2% downsideOvervalued by 73.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.32 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.62 (1.26%) |
| Earnings per Share | $- |
| Beta | 1.57 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 28.18%▼ 1.67% |
|---|---|
| Total Invested | $13.90M▼ 6.19% |
| Investors Holding | 400% |
ESG Score
No data